Magnitude to thrombocytopenia among the patients with novel Middle East respiratory syndrome

Joob, Beuy; Wiwanitkit, Viroj

doi:10.3109/09537104.2014.934796

Cited by 8 publications

(7 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many viral infections can cause thrombocytopenia. Both MERS and SARS can cause peripheral blood PLT reduction 13,14 . In this study, patients with COVID‐19 also showed significantly lower PLT counts, and the PLT count of severe COVID‐19 patients was significantly lower than that of common COVID‐19 and influenza patients.…”

Section: Discussionsupporting

confidence: 46%

Distinguishing between COVID‐19 and influenza during the early stages by measurement of peripheral blood parameters

Chen

Pan

et al. 2020

Journal of Medical Virology

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 infection. This study aims to examine the changes in peripheral blood parameters during the early stages of COVID‐19 and influenza. We analyzed the peripheral blood parameters of 169 COVID‐19 patients and 131 influenza patients during the early‐onset stage. Results from the patients with COVID‐19 were compared with those from healthy controls and influenza patients. In addition, results from patients with common and severe COVID‐19 were further compared. There were significant differences between COVID‐19 and influenza patients in terms of age, white blood cell count, platelet count, percentage of neutrophils, percentage of lymphocytes, percentage of monocytes, percentage of eosinophils, percentage of basophils, neutrophil, count and monocyte count. Two parameters (monocyte count and percentage of basophils) were combined to clarify the diagnostic efficacy of COVID‐19 and influenza and the area under the curve was found to be 0.772. Comparison of peripheral blood parameters from common COVID‐19, severe COVID‐19, and influenza patients revealed many differences during the early disease stages. The diagnostic formula developed by this study will be of benefit for physicians in the differentiation of COVID‐19 and influenza.

show abstract

Section: Discussionsupporting

confidence: 46%

Distinguishing between COVID‐19 and influenza during the early stages by measurement of peripheral blood parameters

Chen

Pan

et al. 2020

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

“…In previous SARS-CoV-1 infections, thrombocytopenia has been commonly observed in patients with severe disease [7]. In the case of the Middle East respiratory syndrome (MERS), anemia, lymphopenia, and thrombocytopenia are common, but severe thrombocytopenia is rare [8,9].…”

Section: Sars-cov-2 Has Clinical Symptoms Similar To Sars-cov-1 and Bmentioning

confidence: 99%

Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19

2021

View full text Add to dashboard Cite

“…3,4 In fact, this is similar observation to that seen in a previous emerging coronavirus infection, Middle East respiratory syndrome. 5 Nevertheless, there is still no report regarding hemorrhagic problem in the patients with COVID-19. Here, the authors would like to present observation from Thailand on 41 patients (4 males and 37 females, age between 7 and 74 years) with COVID-19 in Thailand (based on most update data at February 29, 2020).…”

mentioning

confidence: 99%

Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients

Joob

Wiwanitkit

2020

Clin Appl Thromb Hemost

Self Cite

View full text Add to dashboard Cite

Magnitude to thrombocytopenia among the patients with novel Middle East respiratory syndrome

Cited by 8 publications

References 6 publications

Distinguishing between COVID‐19 and influenza during the early stages by measurement of peripheral blood parameters

Distinguishing between COVID‐19 and influenza during the early stages by measurement of peripheral blood parameters

Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19

Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients

Contact Info

Product

Resources

About